Qin Xing-lei, Xue Huan-zhou, Wang Zuo-ren, Liu Hong-shan, Zhou Huai-bin, Ma Wei
Department of Hepatobiliary Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, China.
Zhonghua Wai Ke Za Zhi. 2009 Dec 15;47(24):1852-6.
To investigate the expression of Survivin in patients with extrahepatic cholangiocarcinoma (EHCC) and its relationship with clinicopathological features of EHCC, and the correlation between the expression of Survivin and lymph node micrometastasis, tumor markers, and the prognosis of EHCC.
The expression of Survivin protein in paraffin-embedded specimens of 59 patients with EHCC and their 20 para-carcinoma tissues were evaluated by S-P method of immunohistochemical staining. The correlation between the expression of Survivin and the lymph node micrometastasis, clinicopathological features of EHCC and the prognosis of EHCC were analyzed.
The positive expression rate of Survivin protein was 67.8% (40/59) in paraffin-embedded specimens of 59 patients with EHCC and was 20.0% (4/20) in para-carcinoma tissues, and difference between carcinoma tissues and para-carcinoma tissues was significant (P<0.01). Histological differentiation in EHCC had a negative correlation with the expression of Survivin protein, while the expression of Survivin protein in EHCC had a positive correlation with TNM of EHCC, lymphatic vessel infiltration, lymph node metastasis and perineural invasion (P<0.05). The serum CA19-9 levels in the positive group with expression of Survivin protein was (290,300+/-55 500) U/L and was obviously higher than that in the negative group [(113,300+/-31,400) U/L, P<0.05]. The mean survival time of the patients with negative expression of Survivin protein was higher than that of the patients with positive expression (43.5 vs. 21.1 months, P<0.01). Screened to significance univariate, the multivariate analysis through Cox proportional hazard model analysis showed that lymph node metastasis, residual tumor margins, and expression of Survivin protein were independent prognosis factors of the patients with EHCC (P<0.05, P<0.01, P<0.01).
The expression of Survivin protein in EHCC has a negative correlation with histological differentiation, while has a positive correlation with lymphatic vessel infiltration and serum CA19-9 concentrations. The expression of Survivin protein maybe an independent prognosis factor of the patients with EHCC.
探讨生存素(Survivin)在肝外胆管癌(EHCC)患者中的表达及其与EHCC临床病理特征的关系,以及Survivin表达与淋巴结微转移、肿瘤标志物和EHCC预后的相关性。
采用免疫组织化学染色S-P法检测59例EHCC患者石蜡包埋标本及其20例癌旁组织中Survivin蛋白的表达。分析Survivin表达与EHCC淋巴结微转移、临床病理特征及EHCC预后的相关性。
59例EHCC患者石蜡包埋标本中Survivin蛋白阳性表达率为67.8%(40/59),癌旁组织中为20.0%(4/20),癌组织与癌旁组织差异有统计学意义(P<0.01)。EHCC的组织学分化与Survivin蛋白表达呈负相关,而EHCC中Survivin蛋白表达与EHCC的TNM分期(国际抗癌联盟制定的恶性肿瘤分期系统)、淋巴管浸润、淋巴结转移及神经周围浸润呈正相关(P<0.05)。Survivin蛋白表达阳性组血清CA19-9水平为(290300±55500)U/L,明显高于阴性组[(113300±31400)U/L,P<0.05]。Survivin蛋白表达阴性患者的平均生存时间高于阳性患者(43.5个月对21.1个月,P<0.01)。单因素分析筛选出有统计学意义的因素后,经Cox比例风险模型多因素分析显示,淋巴结转移、肿瘤切缘残留及Survivin蛋白表达是EHCC患者的独立预后因素(P<0.05,P<0.01,P<0.01)。
Survivin蛋白在EHCC中的表达与组织学分化呈负相关,与淋巴管浸润及血清CA19-9浓度呈正相关。Survivin蛋白表达可能是EHCC患者的独立预后因素。